Position in BMRN
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$537,868
-$361,458 QoQ
Shares Held
9,400
-43.4% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#335
of 561 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMRN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026TD Asset Management Inc holds $1,129,937,988 across 119 Biotechnology names. BMRN ranks #113 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
259,317 | $161,694,522 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
207,960 | $103,299,970 | |
| 3 | HALO |
Halozyme Therapeutics, Inc.
|
1,115,730 | $87,328,187 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
233,696 | $70,349,506 | |
| 5 | CYTK |
Cytokinetics Inc
|
385,130 | $32,809,224 | |
| 6 | RPRX |
Royalty Pharma plc
|
567,497 | $31,819,556 | |
| 7 | ASND |
Ascendis Pharma A/S
|
119,085 | $31,762,351 | |
| 8 | KYMR |
Kymera Therapeutics, Inc.
|
272,900 | $31,293,443 |
All Filings in BMRN
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $537,868 | 9,400 | Shares | Sole | 2026-08-04 | |
| 2025-09-30 | $899,326 | 16,605 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $947,737 | 17,241 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $2,482,774 | 35,122 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $6,187,164 | 94,130 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $7,257,793 | 103,255 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $11,847,040 | 143,897 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $13,853,958 | 158,621 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $18,419,112 | 191,030 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $15,322,258 | 173,172 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $8,705,272 | 100,430 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $10,041,877 | 103,269 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $8,227,558 | 79,501 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $4,663,706 | 55,016 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $4,099,164 | 49,465 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $4,288,533 | 55,623 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $2,485,992 | 28,138 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $2,252,617 | 29,145 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $2,427,186 | 29,089 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $4,839,360 | 64,089 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $5,652,322 | 64,458 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $4,873,304 | 64,055 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $8,777,614 | 71,166 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $5,804,643 | 68,694 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||